Free Trial

Addex Therapeutics (ADXN) Earnings Date, Estimates & Call Transcripts

Addex Therapeutics logo
$7.97 +0.59 (+7.99%)
(As of 01:50 PM ET)

Addex Therapeutics Latest Earnings Summary

Latest Q2 2024
Earnings Date
Sep. 30Confirmed
Actual EPS
(Sep. 30)
-$1.77 Missed By -$1.70
Consensus EPS
(Sep. 30)
-$0.07

Addex Therapeutics announced Q2 2024 earnings on September 30, 2024, reporting an EPS of -$1.77, which missed the consensus estimate of -$0.07 by $1.70. Quarterly revenue was reported to be $0.13 million, below analyst estimates of $0.26 million. With a trailing EPS of -$1.64, Addex Therapeutics' earnings are expected to decrease next year, from $9.80 to ($5.60) per share.

Get Addex Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Addex Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ADXN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADXN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Addex Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20241-$0.07-$0.07-$0.07
Q3 20241-$0.07-$0.07-$0.07
Q4 20241-$0.07-$0.07-$0.07
20243-$0.21-$0.21-$0.21
Q1 20251-$0.21-$0.21-$0.21
Q2 20251$0.00$0.00$0.00
Q3 20251$0.00$0.00$0.00
Q4 20251$0.00$0.00$0.00
FY 20254($0.21)($0.21)($0.21)

Addex Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
9/30/2024Q2 2024-$0.07-$1.77 -$1.70-$14.15$0.26M$0.13M  
6/6/2024Q1 2024--$1.37 -$1.37$1.38-$0.27M
4/18/2024Q4 2023--$4.06 -$4.06-$4.06-$0.21M
11/29/2023Q3 2023-$4.00-$4.07 -$0.07-$4.07$0.70M$0.37M
8/10/2023Q2 2023--$5.00 -$5.00-$0.25-$0.70M
5/11/2023Q1 2023--$5.20 -$5.20-$0.26-$0.54M
3/30/2023Q4 2022--$5.00 -$5.00-$0.25-$0.62M

Addex Therapeutics Earnings - Frequently Asked Questions

Addex Therapeutics (NASDAQ:ADXN) last announced its quarterly earning data on Monday, September 30, 2024. Learn more on ADXN's earnings history.

In the previous quarter, Addex Therapeutics (NASDAQ:ADXN) missed the analysts' consensus estimate of ($0.07) by $1.70 with a reported earnings per share (EPS) of ($1.77). Learn more on analysts' earnings estimate vs. ADXN's actual earnings.

The conference call transcript for Addex Therapeutics's latest earnings report can be read online.
Read Transcript

Addex Therapeutics (NASDAQ:ADXN) has a recorded annual revenue of $1.83 million.

Addex Therapeutics (NASDAQ:ADXN) has a recorded net income of -$11.76 million. ADXN has generated -$1.64 earnings per share over the last four quarters.

Addex Therapeutics's earnings are expected to decrease from $9.80 per share to ($5.60) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:ADXN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners